Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy.

[1]  L. Mofenson,et al.  Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Y. Teerawattananon,et al.  Economic Evaluation of 3-Drug Antiretroviral Regimens for the Prevention of Mother-to-Child HIV Transmission in Thailand , 2015, Asia-Pacific journal of public health.

[3]  C. Thio,et al.  Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  K. Kitrinos,et al.  No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  F. Luciani,et al.  Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations , 2014, Journal of viral hepatitis.

[6]  E. Swenson,et al.  Prevention of neonatal hepatitis B virus transmission. , 2014, Journal of clinical gastroenterology.

[7]  Minal K. Patel,et al.  Findings from a hepatitis B birth dose assessment in health facilities in the Philippines: opportunities to engage the private sector. , 2014, Vaccine.

[8]  S. Locarnini,et al.  Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. , 2014, Journal of hepatology.

[9]  H. Patton,et al.  Management of hepatitis B during pregnancy , 2014, Nature Reviews Gastroenterology &Hepatology.

[10]  H. Coovadia,et al.  Eliminating mother to child transmission of HIV-1 and keeping mothers alive: recent progress. , 2014, The Journal of infection.

[11]  M. Dal,et al.  Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. , 2013, World journal of gastroenterology.

[12]  Y. Huang,et al.  Screening of pregnant women for hepatitis B virus surface antigen (HBsAg) and subsequent management, Qiandongnan prefecture, Guizhou, China, 2010. , 2013, Vaccine.

[13]  Minal K. Patel,et al.  Hepatitis B Vaccine Birthdose Practices in a Country Where Hepatitis B is Endemic — Laos, December 2011–February 2012 , 2013, MMWR. Morbidity and mortality weekly report.

[14]  Hongbin Song,et al.  The next step in controlling HBV in China , 2013, BMJ.

[15]  M. Pedroso,et al.  Comparative Efficacy of Oral Nucleoside or Nucleotide Analog Monotherapy Used in Chronic Hepatitis B: A Mixed‐Treatment Comparison Meta‐analysis , 2013, Pharmacotherapy.

[16]  Debra Jackson,et al.  Eliminating mother-to-child HIV transmission in South Africa. , 2013, Bulletin of the World Health Organization.

[17]  Yali Hu,et al.  Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China , 2012, BMC Infectious Diseases.

[18]  R. Peeling,et al.  Rapid Point-of-Care First-Line Screening Tests for Hepatitis B Infection: A Meta-Analysis of Diagnostic Accuracy (1980–2010) , 2012, The American Journal of Gastroenterology.

[19]  Y. Liaw,et al.  Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. , 2012, Journal of hepatology.

[20]  Gretchen A. Stevens,et al.  The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions , 2012, BMC Infectious Diseases.

[21]  D. Jamieson,et al.  HIV-HBV coinfection--a global challenge. , 2012, The New England journal of medicine.

[22]  Xiaofeng Liang,et al.  An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  A. Walker,et al.  Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial , 2012, PLoS medicine.

[24]  L. Serino,et al.  Hepatitis A: Epidemiology and prevention in developing countries. , 2012, World journal of hepatology.

[25]  Wei Zhao,et al.  A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. , 2011, Journal of hepatology.

[26]  J. Petersen.  HBV treatment and pregnancy. , 2011, Journal of hepatology.

[27]  G. Zuccotti,et al.  In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers , 2011, Antiviral therapy.

[28]  R. Tedder,et al.  Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? , 2010, Bulletin of the World Health Organization.

[29]  Hung‐Chih Yang,et al.  Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study , 2009, Journal of viral hepatitis.

[30]  Y. Liaw,et al.  Telbivudine versus lamivudine in patients with chronic hepatitis B. , 2007, The New England journal of medicine.

[31]  G. Armstrong,et al.  Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. , 2007, Bulletin of the World Health Organization.

[32]  G. Norkrans,et al.  Hepatitis B Virus DNA during Pregnancy and Post Partum: Aspects on Vertical Transmission , 2003, Scandinavian journal of infectious diseases.

[33]  D. Shouval.  Hepatitis B vaccines. , 2003, Journal of hepatology.

[34]  C. Kiire.  The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. , 1996, Gut.

[35]  R. Burk,et al.  Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. , 1994, The Journal of infectious diseases.